Answers are grounded in this paper and cite their sources.
In vitro experimental study demonstrates ultrasensitive lateral flow immunoassays using carboxylated fluorescent nanoparticles, suggesting diagnostic sensitivity comparable to ELISA.
We have developed a one-pot, two-stage method for the synthesis of highly monodispersed fluorescent polystyrene nanoparticles with surface carboxyl functional groups. The fluorescent nanoparticles have a tunable size range of 150−300 nm and excellent photo/chemical stability. Through conjugating antibodies to the surface carboxyl groups, various lateral flow immunoassays (LFIAs) using the fluorescent nanoparticles as the reporters have been developed, achieving a visual limit of detection (LOD) of 39 mIU mL−1 using human chorionic gonadotropin as the model sample. This LOD is 8-fold and 64-fold better as compared to LFIAs using AuNPs and free dye as reporters, respectively. The LODs of our optimized LFIAs are 3 pg mL−1 for HIV-1 p24, 4 ng mL−1 for Zika NS1, and 1 and 0.5 ng mL−1 for Staphylococcus aureus enterotoxin types A and B, respectively. These LOD values are below the clinical cutoffs and are comparable to ELISA results reported in the literature.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: